Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea
- 1 December 1984
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 46 (3) , 845-849
- https://doi.org/10.1128/iai.46.3.845-849.1984
Abstract
Purified polysaccharides (EPS) prepared from the plant Echinacea purpurea are shown to strongly activate macrophages. Macrophages activated with these substances develop pronounced extracellular cytotoxicity against tumor targets. The activation is brought about by EPS alone and is independent of any cooperative effect with lymphocytes. Also the production and secretion of oxygen radicals and interleukin 1 by macrophages is increased after activation with EPS. Cells of the macrophages lineage seem to be the main target for the action of these polysaccharides. EPS has no effect on T lymphocytes. B lymphocytes show a comparatively modest proliferation after incubation with E. purpurea EPS. Thus, these compounds, which are at least in tissue culture completely nontoxic, may be suited to activate in vivo cells of the macrophage system to cytotoxicity. They may therefore be of relevance in tumor and infectious systems.This publication has 15 references indexed in Scilit:
- Requirement for macrophages or for macrophage‐ or T cell‐derived factors in the mitogenic stimulation of murine B lymphocytes by lipopolysaccharidesEuropean Journal of Immunology, 1983
- In Vitro Induction of Intracellular Killing of Parasitic Protozoa by MacrophagesImmunobiology, 1982
- The Role of Cell-Mediated Immunity in Bacterial InfectionsClinical Infectious Diseases, 1981
- Galactosamine-induced sensitization to the lethal effects of endotoxin.Proceedings of the National Academy of Sciences, 1979
- Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.The Journal of Experimental Medicine, 1978
- Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.Proceedings of the National Academy of Sciences, 1977
- Studies on the activation of mouse bone marrow‐derived macrophages by the macrophage cytotoxicity factor (MCF)European Journal of Immunology, 1976
- The Functions of the Macrophage in Malignant DiseaseAnnual Review of Medicine, 1976
- BCG and CancerNew England Journal of Medicine, 1974
- Immunity to Infection, Allograft Immunity and Tumour Immunity: Parallels and ContrastsImmunological Reviews, 1974